The appointment further strengthens the Company’s leadership position in the use of technology to develop psychedelic-related treatments VANCOUVER, BC, Feb. 22, 2021 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( “Mind Cure” or the “Company”), a leader in developing technology to create psychedelic-related treatments, is pleased to announce the addition of Rob Hill to the…

Source

Previous articleAwakn Chief Medical Officer, Dr. Ben Sessa, Announces Results of the World’s First ‘MDMA in Alcohol Use Disorder’ Clinical Trial
Next articleThe Benefits of Mescaline: How An Ancient Cactus Became a Future Medicine